214 related articles for article (PubMed ID: 18254013)
61. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome.
Saito YA; Almazar AE; Tilkes KE; Choung RS; Van Norstrand MD; Schleck CD; Zinsmeister AR; Talley NJ
Aliment Pharmacol Ther; 2019 Feb; 49(4):389-397. PubMed ID: 30663077
[TBL] [Abstract][Full Text] [Related]
62. Cisapride for intestinal constipation.
Aboumarzouk OM; Agarwal T; Antakia R; Shariff U; Nelson RL
Cochrane Database Syst Rev; 2011 Jan; (1):CD007780. PubMed ID: 21249695
[TBL] [Abstract][Full Text] [Related]
63. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
64. Validation of the Rome III criteria and alarm symptoms for recurrent abdominal pain in children.
Gijsbers CF; Benninga MA; Schweizer JJ; Kneepkens CM; Vergouwe Y; Büller HA
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):779-85. PubMed ID: 24866784
[TBL] [Abstract][Full Text] [Related]
65. The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double-blind, randomized, controlled trial.
Feldman W; McGrath P; Hodgson C; Ritter H; Shipman RT
Am J Dis Child; 1985 Dec; 139(12):1216-8. PubMed ID: 2998181
[TBL] [Abstract][Full Text] [Related]
66. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
Quigley EM; Tack J; Chey WD; Rao SS; Fortea J; Falques M; Diaz C; Shiff SJ; Currie MG; Johnston JM
Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
[TBL] [Abstract][Full Text] [Related]
67. Methodological challenges to treatment trials for recurrent abdominal pain in children.
Ball TM; Weydert JA
Arch Pediatr Adolesc Med; 2003 Nov; 157(11):1121-7. PubMed ID: 14609904
[TBL] [Abstract][Full Text] [Related]
68. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.
Chiou E; Nurko S
Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):293-304. PubMed ID: 20528117
[TBL] [Abstract][Full Text] [Related]
69. The use of non-narcotic pain medication in pediatric gastroenterology.
Miranda A; Saps M
Paediatr Drugs; 2014 Aug; 16(4):293-307. PubMed ID: 24942827
[TBL] [Abstract][Full Text] [Related]
70. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Hawrelak JA; Wohlmuth H; Pattinson M; Myers SP; Goldenberg JZ; Harnett J; Cooley K; Van De Venter C; Reid R; Whitten DL
Complement Ther Med; 2020 Jan; 48():102233. PubMed ID: 31987249
[TBL] [Abstract][Full Text] [Related]
71. Pain in irritable bowel syndrome: Does anything really help?
BouSaba J; Sannaa W; Camilleri M
Neurogastroenterol Motil; 2022 Jan; 34(1):e14305. PubMed ID: 34859929
[TBL] [Abstract][Full Text] [Related]
72. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
Ingrosso MR; Ianiro G; Nee J; Lembo AJ; Moayyedi P; Black CJ; Ford AC
Aliment Pharmacol Ther; 2022 Sep; 56(6):932-941. PubMed ID: 35942669
[TBL] [Abstract][Full Text] [Related]
73. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
Ford AC; Talley NJ; Spiegel BM; Foxx-Orenstein AE; Schiller L; Quigley EM; Moayyedi P
BMJ; 2008 Nov; 337():a2313. PubMed ID: 19008265
[TBL] [Abstract][Full Text] [Related]
74. Evaluating the effects of probiotics in pediatrics with recurrent abdominal pain.
Rahmani P; Ghouran-Orimi A; Motamed F; Moradzadeh A
Clin Exp Pediatr; 2020 Dec; 63(12):485-490. PubMed ID: 32718147
[TBL] [Abstract][Full Text] [Related]
75. Assessment of abdominal pain through global outcomes and recent FDA recommendations in children: are we ready for change?
Mohammad S; Di Lorenzo C; Youssef NN; Miranda A; Nurko S; Hyman P; Saps M
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):46-50. PubMed ID: 23857339
[TBL] [Abstract][Full Text] [Related]
76. WITHDRAWN: Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.
Huertas-Ceballos AA; Logan S; Bennett C; Macarthur C; Martin AE
Cochrane Database Syst Rev; 2014 Feb; (2):CD003019. PubMed ID: 24535946
[No Abstract] [Full Text] [Related]
77. The Management of Paediatric Functional Abdominal Pain Disorders: Latest Evidence.
Brusaferro A; Farinelli E; Zenzeri L; Cozzali R; Esposito S
Paediatr Drugs; 2018 Jun; 20(3):235-247. PubMed ID: 29497992
[TBL] [Abstract][Full Text] [Related]
78. Occult constipation: faecal retention as a cause of recurrent abdominal pain in children.
Gijsbers CF; Kneepkens CM; Vergouwe Y; Büller HA
Eur J Pediatr; 2014 Jun; 173(6):781-5. PubMed ID: 24384798
[TBL] [Abstract][Full Text] [Related]
79. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood.
Horvath A; Dziechciarz P; Szajewska H
Aliment Pharmacol Ther; 2011 Jun; 33(12):1302-10. PubMed ID: 21507030
[TBL] [Abstract][Full Text] [Related]
80. Recurrent abdominal pain among a sample of Egyptian children in relation to family and school related problems.
Abd El-Mageid FY; Abou-El Fetouh AM; Abou-Hatab MF
J Egypt Public Health Assoc; 2002; 77(1-2):201-23. PubMed ID: 17219898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
